Hempire Pharma (Japan), a subsidiary of Hempire Technology Group, has launched エンディミン®, for patients with Alzheimer's disease and Parkinson's disease. エンディミン® is developed based on the company's patented neurodegenerative diseases and uses a specific cannabinoid composition as the main ingredient.

Price: JPY￥100,000.00

Free Shipping to: Japan

Country of Origin: Japan

Ingredients: Cannabinoid Combinations (0 THC)
Patent number: Japanese Patent No. 7220818

Product specifications: 30mL

Product Usage and Precaution: Please refer to the instructions for use on the package

How to place an order?

Please place the order by bank transaction:

Bank: MUFG Bank, LTD

Branch：Kasugacho Branch

Bank address: 1-1-1, Koishikawa, Bunkyo-ku, Tokyo, Japan

Swift code: BOTKJPJT

Bank Phone No.: 090-6608-8758

Account Name: Hempire Pharma Co., Ltd.

Account No.: 0621108787

Address: 3-2-3, Kumoidori, Chuo Ward, Kobe, Hyogo, Japan

After completing the transfer, please send the transfer voucher together with the detailed delivery address (Japan address, name of the consignee, contact number of the consignee) to the e-mail: contact@hempiretechgroup.com, we will arrange the delivery as soon as possible after receiving your mail. Thank you for your support!